Cargando…
CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients
Autores principales: | Hartog, Christiane S, Reinhart, Konrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672563/ https://www.ncbi.nlm.nih.gov/pubmed/23134688 http://dx.doi.org/10.1186/cc11673 |
Ejemplares similares
-
Concerns about renal safety of HES 130
por: Wiedermann, Christian J, et al.
Publicado: (2013) -
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study
por: Guidet, Bertrand, et al.
Publicado: (2012) -
Concerns over use of hydroxyethyl starch solutions
por: Hartog, Christiane S, et al.
Publicado: (2014) -
ROCKET AF adds more concerns about Digoxin safety in patients with atrial fibrillation
por: ElMaghawry, Mohamed
Publicado: (2015) -
Does the ICU experience predict psychological symptoms in relatives of patients with severe sepsis and end-of-life decisions?
por: Hartog, Christiane, et al.
Publicado: (2013)